Skip to search.
 FTSE 100 Down 0.29%

Inovio Pharmaceuticals, Inc. (INO)

-NasdaqGS
9.32 Up 0.06(0.65%) 30 Sep 21:00
|After Hours: : 9.32 0.00 (0.00%) 30 Sep 21:59
Prev Close:9.26
Open:9.28
Bid:9.21 x 500
Ask:9.55 x 400
1y Target Est:19.75
Beta:1.84632
Earnings Date:7 Nov - 11 Nov (Est.)
Day's Range:9.15 - 9.46
52wk Range:4.50 - 11.69
Volume:876,626
Avg Vol (3m):1,236,870
Market Cap:685.47m
P/E (ttm):N/A
EPS (ttm):-0.55
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Headlines

  • No Headlines available for INO at this time.

Comparison

Symbol% ChgMkt Cap
INOUp 0.65%685.47m
PFEUp 1.65%205.44b
AZNDown 0.57%81.61b

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):15.33
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-16) :-0.93
Quarterly EPS Est (Sep-16) :-0.27
Mean Recommendation*:1.8
PEG Ratio (5 yr expected):N/A

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Inovio Pharmaceuticals, Inc., a clinical stage biopharmaceutical company, develops active DNA immunotherapies and vaccines in combination with proprietary electroporation delivery devices to prevent and treat cancers and infectious diseases. more
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback